Article Details
Retrieved on: 2024-12-02 15:28:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Trinity Biotech is also progressing in the development of a next-generation Continuous Glucose Monitor (CGM) targeting the diabetes management market.
Article found on: uk.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here